Exploring ‘Sherlock’s Corner’ of Mederi Medicine

“When one tries to rise above nature, one is liable to fall below it.”
– Sherlock Holmes

Exploring ‘Sherlock’s Corner’ of Mederi Medicine

From a wholistic perspective, cancer and other complex diseases require a deep investigation in several areas and involves the layering of various lenses, both macro and micro. Aptly, the Mederi Medicine approach has been greatly influenced by the problem-solving methods of the fictional detective, Sherlock Holmes. This is why I refer to the investigational component of Mederi Medicine as “Sherlock’s Corner”, to pay homage to Holmes’ logic.

Of equal relevance to the exploration, collection, and analysis of data in medicine is the understanding and application of hermeneutics. Hermeneutics is the science and method of interpretation, the process that helps us determine what is most relevant when considering the information within the context of a patient’s life story, which involves communication and relationship. Dr. Drew Leder explains that “Clinical medicine can best be understood not as a purified science, but as a hermeneutical enterprise: that is, as involved with the interpretation of (methodological) texts.” He suggests that the hermeneutics of medicine can be broken down into four text categories: “the “experiential text” as the patient’s experience of the illness; the “narrative text” as the history of the illness; the “physical text” as the objective examination of the patient’s body; the “instrumental text” as the construction by diagnostic technologies.” The information generated, when pooled together, can be useful in developing an understanding of the underlying disease, as well as a treatment plan. Leder further suggests that: “Certain flaws in modern medicine arise from its refusal of a hermeneutic self-understanding…in seeking to escape all interpretive subjectivity, medicine has threatened to expunge its primary subject–the living, experiencing patient.”[1]

September 10, 2020March 22, 2022

Our True Job in Medicine

Thoughts and Insights into Mederi-Care

“We are living in an era of the most sophisticated technological advances, yet the treatment of cancer is paleolithic.” ~Azra Raza MD

The foundation of Mederi Medicine has always been to support people in thriving, not merely surviving, in the journey of life. Recently, I’ve been reading the book “Being Mortal: Medicine and What Matters in the End” by surgeon, professor, and public health researcher, Atul Gawande.

Dr. Gawande writes eloquently about what matters most in medicine. Now, more than ever, we need to hear these words of wisdom.

May 13, 2020March 28, 2022

Health Optimization and Adaptogens

Health Optimization and Adaptogens – An Effective Strategy Against Pathogens

In general, I am astonished by how little attention is placed on the value and importance of good health in our society. In the face of the current pandemic, with underlying co-morbidities present in an estimated 60% of the population, increasing the risk of death from complications, there is an even greater urgency to educate our communities and urge our citizens to adopt the key components to optimal health. For example, there is now a clear association between diabetes and increased mortality and severity in COVID-19 pneumonia, and ocular symptoms of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2).[1] These and many other underlying conditions can be successfully managed by applying the fundamental building blocks to optimal health and wellness, which include nutrition, botanical medicine, lifestyle, and diet. The more robust our health at the molecular, cellular, and organ system levels, the better equipped we are to resist and recover from disease.

July 18, 2019May 17, 2022

Mederi Medicine and the Application of Hermeneutics

More people are reaching a ripe old age than ever before in history. In the early 1800s, life expectancy was a mere 45 years. But today, in Australia, Canada, Japan, and most European countries, people can expect to live to 80 and beyond. If the trend continues, a majority of babies born in these countries will live past their 100th birthday. But this increase in longevity comes with some bad news. Although we manage to survive longer than preceding generations, we often gain time without being healthier in those extra years.

The Difference Between Thriving and Surviving as We Age

Studies worldwide indicate that after age 60, most people have at least one chronic disorder, such as heart disease or diabetes. A recent population-based study in Sweden found that at age 80, only one of 10 individuals were living well and not suffering from either a chronic disease or Frailty Syndrome.

In the U.S. almost one-third of people older than 85 have received an Alzheimer’s diagnosis, often combined with other types of dementia such as that caused by vascular disease.¹

What’s Wrong with Our Modern Medicine Healthcare Model?

Modern Medicine faces fundamental challenges in that we are removing the human element and attempting to reduce everything to a single cause and effect. Given the functional interdependencies between the molecular components in a human cell, disease is rarely a consequence of an abnormality in a single gene, but reflects the perturbations of the complex intracellular and intercellular network that links tissue and organ systems.²

February 6, 2019April 14, 2022

Understanding Neutrophil to Lymphocyte Ratio (Part 2): Research Demonstrating its Role as a Valuable Prognostic Marker in Cancer

Understanding Neutrophil to Lymphocyte Ratio (Part 2): Research Demonstrating its Role as a Valuable Prognostic Marker in Cancer

A large body of research (as well as my clinical observations) point to chronic inflammation as a powerful force in the initiation, growth, and spread of cancer. As a result, an essential component of my protocol for health includes addressing inflammation.

As I discussed in part 1 of this series, there are three points to consider when evaluating the role of inflammation in cancer. First, a chronic inflammatory state can initiate cancer development. Second, it’s important to discover and address the root cause of the inflammation—for example, pathogenic (chronic infection), life-style, stress, and/or poor dietary habits. And third, recognize that the cancer itself creates inflammation—as the cancer energy mutates and gains intelligence, it manipulates the immune system, creating a pro-inflammatory micro-environment favorable to cancer growth.

Research indicates that the systemic manifestations of inflammation can provide a valuable biomarker for prognosis and treatment stratification. In particular, numerous studies indicate that a simple indicator of systemic inflammation—based on neutrophilia and/or lymphocytopenia—can provide prognostic information in a wide range of cancer types. In particular, the value of one index (the dNLR) derived from total white cell and neutrophil counts, is enabling large retrospective studies to be carried out.

Neutrophil to Lymphocyte Ratio May Be a Predictor of Mortality in All Conditions

White blood cell (WBC) count is one of the useful inflammatory biomarkers in clinical practice. For example, even if WBC is within normal range, subtypes of WBC including N/L ratio may predict cardiovascular mortality.

N/L ratio is a readily measurable laboratory marker used to evaluate systemic inflammation. There are many different conditions that can affect N/L ratio, including hypertension, diabetes mellitus, metabolic syndrome (1), left ventricular dysfunction, acute coronary syndromes, valvular heart disease, abnormal thyroid function tests, renal or hepatic dysfunction, known malignancy (2,3,4), local or systemic infection, previous history of infection (<3 months), inflammatory diseases, and any medication related to inflammatory conditions.

Here’s one example of how the N/L ratio can be useful as part of the evaluation of a specific cancer and the treatment protocol: not only N/L ratio but also mean platelet volume, red cell distribution width (5), platelet distribution width, CRP, uric acid and gamma-glutamyl transferase (6) are easy markers to evaluate the prognosis of colon cancer patients (7). However, one should keep in mind that N/L ratio itself alone without other inflammatory markers may not give exact information to clinicians about the prognosis of colon cancer patients. (8,9).

Continue reading “Understanding Neutrophil to Lymphocyte Ratio (Part 2): Research Demonstrating its Role as a Valuable Prognostic Marker in Cancer”

December 11, 2018April 23, 2022

‘Misrepresentation of ‘Integrative Oncology’ in the Literature: Clearing up Misperceptions and Recognizing the Validity of Herbal Medicine at the Forefront of ‘Unified Medicine’

I recently read a paper entitled “Integrative Oncology” ¹published in a peer-reviewed medical journal. To say I was shocked at the misrepresentation presented as “fact” is an understatement.

I am strongly compelled to offer a rebuttal to this article. I can only hope that those who most need the perspective of someone who has worked in clinical practice with cancer patients on a daily basis for almost three decades will benefit from my experience.

Personally, I prefer to use the term “Unified Medicine” over “Integrative Oncology” to more appropriately describe the wholistic ETMS (Eclectic Triphasic Medical System) model I developed and practice, known as ‘Mederi Medicine’ or ‘Mederi Care’.

Mederi Medicine is an approach where all aspects of an individual are addressed for optimal health and well being. This includes the fundamental building blocks of nutrition, herbs, lifestyle, and spiritual and emotional health, with the tools of modern conventional medicine employed when necessary. As a musician, I think of Mederi Medicine as similar to the way that the various parts of an orchestra each play an essential role in creating beautiful music. The ETMS is not a fragmented approach, but is synergistic, meaning that the whole is greater than the sum of its parts. This harmonious approach is something that is sorely lacking in modern conventional medicine”.

*“I think of Mederi Medicine as similar to the way that the various parts of an orchestra each play an essential role in creating beautiful music”*

What’s Wrong with the “Integrative Oncology” Paper?

Honestly, when I first saw the title “Integrative Oncology” I felt hopeful. I thought perhaps this paper would offer helpful information to those suffering from cancer, or to those who dedicate their lives to working with people with cancer. Instead, I found bias, misrepresentation, and outright twisting of the facts and outcomes of studies. This paper clearly states that it has been peer-reviewed, but given the many errors, I find that difficult to believe.

I find it strange that the subtext delineates “integrative approaches (e.g., lifestyle, meditation, yoga, acupuncture, massage)” but overlooks botanical and nutritional medicines, which are widely used as adjunct therapies in cancer protocols. I have no idea what the underlying agenda is in this paper. Why would scientifically and clinically proven modalities be dismissed or overlooked when they offer the potential for help without harm? Continue reading “‘Misrepresentation of ‘Integrative Oncology’ in the Literature: Clearing up Misperceptions and Recognizing the Validity of Herbal Medicine at the Forefront of ‘Unified Medicine’”